Clinical trial
Use of Maraviroc (MVC) in Immunological Non-responder HIV-1-infected Patients.
NCT00884858 is registered in ClinicalTrials.gov with ASST Fatebenefratelli Sacco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Maraviroc (MVC) in Immunological Non-responder HIV-1-infected Patients.
- Lead sponsor
- ASST Fatebenefratelli Sacco
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- April 30, 2011
- Enrollment
- 100 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.